Literature DB >> 11516228

'Cor placentale': placental intervillus/intravillus blood flow mismatch is the pathophysiological mechanism in severe intrauterine growth restriction due to uteroplacental disease.

N J Sebire1, D Talbert.   

Abstract

The underlying pathophysiology in most cases of severe intrauterine growth restriction and pre-eclampsia is thought to be abnormal and inadequate conversion of the branches of the uterine arteries into low resistance uteroplacental vessels, due to poor extravillous trophoblastic invasion, leading to reduced intervillous blood flow. Since, in most vascular beds the main site of flow resistance is at the level of the small arteries/arterioles rather than the capillary bed itself it is likely that in cases of intrauterine growth restriction due to uteroplacental dysfunction with abnormal fetal umbilical artery flow velocity waveforms, the underlying pathological mechanism is primarily an initial reduction in intervillus flow leading to relative local hypoxia of some villus territories. This results initially in autocrine/paracrine mediated localized stem artery vasoconstriction to minimize intervillus/intravillus flow mismatch which, when widespread, will result in abnormal umbilical artery Doppler waveforms due to the globally increased resistance to fetoplacental flow. Since, a small reduction in vessel radius will result in an exponential increase in flow resistance and reduction in flow, the magnitude of stem vessel constriction need only be small to result in large changes in fetoplacental vascular haemodynamics. Thus, the underlying progressive pathology in this condition may be cardiac failure, secondary to chronic stem vessel vasoconstriction caused by abnormalities in oxygenation of the fetal respiratory system hence the term 'cor placentale' is proposed. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11516228     DOI: 10.1054/mehy.2001.1347

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  2 in total

1.  Estrogen receptor-β and fetoplacental endothelial prostanoid biosynthesis: a link to clinically demonstrated fetal growth restriction.

Authors:  Emily J Su; Linda Ernst; Nadine Abdallah; Robert Chatterton; Hong Xin; Diana Monsivais; John Coon; Serdar E Bulun
Journal:  J Clin Endocrinol Metab       Date:  2011-08-10       Impact factor: 5.958

2.  The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation.

Authors:  Tinnakorn Chaiworapongsa; Jimmy Espinoza; Francesca Gotsch; Yeon Mee Kim; Gi Jin Kim; Luis F Goncalves; Samuel Edwin; Juan Pedro Kusanovic; Offer Erez; Nandor Gabor Than; Sonia S Hassan; Roberto Romero
Journal:  J Matern Fetal Neonatal Med       Date:  2008-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.